{"id":"https://openalex.org/W2056086567","doi":"https://doi.org/10.1017/s1461145711000113","title":"Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia","display_name":"Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia","alternate_titles":[],"publication_year":2011,"publication_date":"2011-02-18","ids":{"openalex":"https://openalex.org/W2056086567","doi":"https://doi.org/10.1017/s1461145711000113","mag":"2056086567","pmid":"https://pubmed.ncbi.nlm.nih.gov/21329556","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3179552"},"language":"en","primary_location":{"id":"doi:10.1017/s1461145711000113","doi":"https://doi.org/10.1017/s1461145711000113","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1461145711000113","pdf_url":"https://academic.oup.com/ijnp/article-pdf/15/1/69/2699284/15-1-69.pdf","source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Neuropsychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2056086567"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/ijnp/article-pdf/15/1/69/2699284/15-1-69.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006354976","display_name":"Daniel J. Lodge","orcid":"https://orcid.org/0000-0002-6772-1748","observed_orcids":["https://orcid.org/0000-0002-6772-1748"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Daniel J. Lodge","raw_affiliation_strings":["Departments of Neuroscience, Psychiatry, and Psychology, University of Pittsburgh, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Neuroscience, Psychiatry, and Psychology, University of Pittsburgh, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017491269","display_name":"Anthony A. Grace","orcid":"https://orcid.org/0000-0003-1864-5504","observed_orcids":["https://orcid.org/0000-0003-1864-5504"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anthony A. Grace","raw_affiliation_strings":["Departments of Neuroscience, Psychiatry, and Psychology, University of Pittsburgh, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Neuroscience, Psychiatry, and Psychology, University of Pittsburgh, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5006354976"],"corresponding_institution_ids":["https://openalex.org/I170201317"],"apc_list":{"value":2042,"currency":"GBP","value_usd":2693},"apc_paid":null,"fwci":1.7877,"has_fulltext":true,"cited_by_count":54,"citation_normalized_percentile":{"value":0.81732462,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"15","issue":"01","first_page":"69","last_page":"76"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.015300000086426735,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ventral-tegmental-area","display_name":"ventral tegmental area","score":0.8360000252723694},{"id":"https://openalex.org/keywords/dopaminergic-neurons","display_name":"dopaminergic neurons","score":0.6759999990463257},{"id":"https://openalex.org/keywords/amphetamine-sensitization","display_name":"amphetamine sensitization","score":0.9810000061988831},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.6019999980926514},{"id":"https://openalex.org/keywords/hyperdopaminergic-state","display_name":"hyperdopaminergic state","score":0.777999997138977},{"id":"https://openalex.org/keywords/nucleus-accumbens","display_name":"nucleus accumbens","score":0.8259999752044678},{"id":"https://openalex.org/keywords/goal-directed-behavior","display_name":"goal-directed behavior","score":0.7919999957084656},{"id":"https://openalex.org/keywords/substance-use-disorders","display_name":"substance use disorders","score":0.5839999914169312}],"concepts":[{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.8644441366195679},{"id":"https://openalex.org/C2780948874","wikidata":"https://www.wikidata.org/wiki/Q640562","display_name":"Ventral tegmental area","level":4,"score":0.8270899057388306},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.7474867105484009},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.6284530758857727},{"id":"https://openalex.org/C2776552330","wikidata":"https://www.wikidata.org/wiki/Q1476178","display_name":"Nucleus accumbens","level":3,"score":0.5957569479942322},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5306982398033142},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5079699158668518},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.42924314737319946},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.32480424642562866},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2504350543022156},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.10013008117675781},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000200","descriptor_name":"Action Potentials","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008746","descriptor_name":"Methylazoxymethanol Acetate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D011247","descriptor_name":"Pregnancy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011297","descriptor_name":"Prenatal Exposure Delayed Effects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017557","descriptor_name":"Ventral Tegmental Area","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017557","descriptor_name":"Ventral Tegmental Area","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D059290","descriptor_name":"Dopaminergic Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D059290","descriptor_name":"Dopaminergic Neurons","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1017/s1461145711000113","doi":"https://doi.org/10.1017/s1461145711000113","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1461145711000113","pdf_url":"https://academic.oup.com/ijnp/article-pdf/15/1/69/2699284/15-1-69.pdf","source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmid:21329556","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21329556","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The international journal of neuropsychopharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3179552","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3179552/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Int J Neuropsychopharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1017/s1461145711000113","doi":"https://doi.org/10.1017/s1461145711000113","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1461145711000113","pdf_url":"https://academic.oup.com/ijnp/article-pdf/15/1/69/2699284/15-1-69.pdf","source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Neuropsychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1137172967","display_name":null,"funder_award_id":"DA 15408","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G3327348677","display_name":null,"funder_award_id":"MH-57440","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G560912870","display_name":"Stress-Induced Alterations in Amygdala-LC Interactions","funder_award_id":"R56DA015408","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G5815116194","display_name":null,"funder_award_id":"MH57440","funder_id":"https://openalex.org/F4320332505","funder_display_name":"U.S. Public Health Service"},{"id":"https://openalex.org/G7554535290","display_name":"Stress-Induced Alterations in Amygdala-LC Interactions","funder_award_id":"R01DA015408","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G7794479402","display_name":null,"funder_award_id":"DA15408","funder_id":"https://openalex.org/F4320332505","funder_display_name":"U.S. Public Health Service"},{"id":"https://openalex.org/G8936947483","display_name":"Gating of Information Flow Within the Nucleus Accumbens","funder_award_id":"R37MH057440","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G9000918704","display_name":"Gating of Information Flow Within the Nucleus Accumbens","funder_award_id":"R01MH057440","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320311440","display_name":"National Alliance for Research on Schizophrenia and Depression","ror":"https://ror.org/03a63f080"},{"id":"https://openalex.org/F4320332505","display_name":"U.S. Public Health Service","ror":"https://ror.org/05xf94514"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2056086567.pdf","grobid_xml":"https://content.openalex.org/works/W2056086567.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W50693228","https://openalex.org/W1671111160","https://openalex.org/W1755010820","https://openalex.org/W1949404224","https://openalex.org/W1964043050","https://openalex.org/W1964381117","https://openalex.org/W1980571433","https://openalex.org/W1982814832","https://openalex.org/W1992238026","https://openalex.org/W1994818402","https://openalex.org/W1994984635","https://openalex.org/W1996327177","https://openalex.org/W1999984108","https://openalex.org/W2009429333","https://openalex.org/W2010341502","https://openalex.org/W2033636209","https://openalex.org/W2045243340","https://openalex.org/W2055776558","https://openalex.org/W2064522533","https://openalex.org/W2064956571","https://openalex.org/W2073734156","https://openalex.org/W2076704115","https://openalex.org/W2079567912","https://openalex.org/W2081362935","https://openalex.org/W2092820864","https://openalex.org/W2093024075","https://openalex.org/W2099185967","https://openalex.org/W2109865728","https://openalex.org/W2116663526","https://openalex.org/W2137924108","https://openalex.org/W2150299732","https://openalex.org/W2155353589","https://openalex.org/W2163815564","https://openalex.org/W7073614719"],"related_works":["https://openalex.org/W2116663526","https://openalex.org/W4307054474","https://openalex.org/W2888101662","https://openalex.org/W2037051573","https://openalex.org/W4311707492","https://openalex.org/W2052817262","https://openalex.org/W1987674940","https://openalex.org/W3130156255","https://openalex.org/W2997113181","https://openalex.org/W2795343256"],"abstract_inverted_index":{"Aberrant":[0],"dopamine-mediated":[1],"behaviours":[2],"are":[3,74],"a":[4,7,49,122,188,193],"hallmark":[5],"of":[6,9,26,62,82,89,101,110,126,190,211],"number":[8,189],"psychiatric":[10],"disorders,":[11],"including":[12],"substance":[13],"use":[14],"disorders":[15,191],"and":[16,52,70],"schizophrenia.":[17,127],"It":[18,40],"has":[19],"been":[20],"demonstrated":[21],"recently":[22],"that":[23,44,53,131,143],"rodent":[24,124],"models":[25,133],"these":[27,68],"diseases":[28],"display":[29,134],"enhanced":[30],"dopamine":[31,55,72,91,102,140,167,200],"neuron":[32,56,103,201],"activity":[33,105],"throughout":[34],"the":[35,45,54,99,107,111,146,208,218],"ventral":[36],"tegmental":[37],"area":[38],"(VTA).":[39],"is":[41,47,173,205],"known,":[42],"however,":[43],"VTA":[46,112],"not":[48],"homogeneous":[50],"structure,":[51],"population":[57,104,202],"provides":[58],"discrete,":[59],"topographical":[60],"innervation":[61],"nucleus":[63],"accumbens":[64],"subregions.":[65],"In":[66,156,182],"addition,":[67],"ventromedial":[69],"ventrolateral":[71],"systems":[73],"known":[75],"to":[76,150],"subserve":[77],"complementary":[78],"but":[79],"distinct":[80],"aspects":[81],"goal-directed":[83],"behaviour.":[84],"Using":[85],"in-vivo":[86],"extracellular":[87],"recordings":[88],"identified":[90],"neurons":[92,212],"in":[93,153,164,179,199,207,221],"chloral":[94],"hydrate-anaesthetized":[95],"rats,":[96],"we":[97,129,184],"examined":[98],"level":[100],"across":[106],"mediolateral":[108],"extent":[109],"following":[113],"amphetamine":[114,151],"sensitization":[115],"or":[116],"gestational":[117],"methylazoxymethanol":[118],"acetate":[119],"(MAM)":[120],"treatment,":[121],"verified":[123],"model":[125],"Here":[128],"demonstrate":[130,185,196],"both":[132,154],"an":[135,162,197],"augmented":[136,147],"medial":[137],"VTA-ventromedial":[138],"striatal":[139,166],"system":[141,168],"function":[142],"correlates":[144],"with":[145,175],"locomotor":[148],"response":[149],"observed":[152,219],"models.":[155],"contrast,":[157],"only":[158],"MAM-treated":[159],"rats":[160],"exhibit":[161],"increase":[163,198],"VTA-ventrolateral":[165],"function.":[169],"This":[170,214],"latter":[171],"finding":[172],"consistent":[174],"human":[176],"imaging":[177],"studies":[178],"schizophrenia":[180],"patients.":[181],"summary,":[183],"that,":[186],"although":[187],"involving":[192],"hyperdopaminergic":[194],"state":[195],"activity,":[203],"there":[204],"divergence":[206],"exact":[209],"populations":[210],"affected.":[213],"distinction":[215],"probably":[216],"underlies":[217],"differences":[220],"disease":[222],"symptomatology.":[223]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2056086567","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
